(2-(3-Methoxypropoxy)phenyl)boronic acid, 97%, 250mg

(4S,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride, 98%, 250mg

(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione, 95.0%, 100g

tert-Butyl (3-Oxo-3-phenylpropyl)carbamate>98.0%(HPLC)100mg

Matraces de fondo redondo de tres bocas con cuellos laterales paralelos, 100 ml, 29/32, 29/32, 1 unidad

METHYL 4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBOXYLATE, 95%, 100mg

Methyl 4-methanesulfonylbenzoate, 95.0%, 10g

N-(2-fluorobenzyl)-N-methylguanidine sulfate, 95.0%, 10g

Methyl 8-quinolinecarboxylate, 98%, 5g

tert-Butyl (1R*,4R*)-4-(isobutylamino)cyclohexylcarbamate, 1g

7-chloro-1,3-benzoxazole-2-thiol, 97%, 1g

5-Methyl-2-(2-trifluoromethyl-phenyl)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

4-Bromo-2-nitrobenzaldehyde, 95.0%, 500g